Cargando…
Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use
Many studies have demonstrated the short-term efficacy and tolerability of methylphenidate treatment adolescents with attention deficit hyperactivity disorder (ADHD). Qualitative literature on this matter focused on school outcomes, long-term side effects, family conflicts, personality changes and s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006242/ https://www.ncbi.nlm.nih.gov/pubmed/36899043 http://dx.doi.org/10.1038/s41598-023-30921-4 |
_version_ | 1784905270139289600 |
---|---|
author | Sibeoni, Jordan Manolios, Emilie Hausser, Clement Delage, Raphael Baylé, Franck Speranza, Mario Verneuil, Laurence Revah-Levy, Anne |
author_facet | Sibeoni, Jordan Manolios, Emilie Hausser, Clement Delage, Raphael Baylé, Franck Speranza, Mario Verneuil, Laurence Revah-Levy, Anne |
author_sort | Sibeoni, Jordan |
collection | PubMed |
description | Many studies have demonstrated the short-term efficacy and tolerability of methylphenidate treatment adolescents with attention deficit hyperactivity disorder (ADHD). Qualitative literature on this matter focused on school outcomes, long-term side effects, family conflicts, personality changes and stigmatization. Yet, no qualitative study has crossed the perspectives of child and adolescent psychiatrists (CAPs) prescribing methylphenidate and adolescents with ADHD. This French qualitative study followed the five stages IPSE—Inductive Process to analyze the Structure of lived Experience-approach. Fifteen adolescents with ADHD and 11 CAPs were interviewed. Data collection by purposive sampling continued until data saturation was reached. Data analysis, based on a descriptive and structuring procedure to determine the structure of lived experience characterized by the central axes of experience, produced two axes: (1) The process of methylphenidate prescription, highlighting how this prescription was motivated from the exterior, experienced as passive by the adolescents and required commitment from the CAPs; and (2) the perceived effects of methylphenidate treatment, in three domains: at school, in relationships and in the sense of self. Findings raised both the issues of the epistemic position and social representation of the adolescents about ADHD and methylphenidate within this specific French context, and the self-awareness and perception of the adolescents with ADHD. We conclude that these two issues need to be regularly addressed by the CAPs prescribing methylphenidate to avoid epistemic injustice and prevent the harmful effects of stigmatization. |
format | Online Article Text |
id | pubmed-10006242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100062422023-03-12 Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use Sibeoni, Jordan Manolios, Emilie Hausser, Clement Delage, Raphael Baylé, Franck Speranza, Mario Verneuil, Laurence Revah-Levy, Anne Sci Rep Article Many studies have demonstrated the short-term efficacy and tolerability of methylphenidate treatment adolescents with attention deficit hyperactivity disorder (ADHD). Qualitative literature on this matter focused on school outcomes, long-term side effects, family conflicts, personality changes and stigmatization. Yet, no qualitative study has crossed the perspectives of child and adolescent psychiatrists (CAPs) prescribing methylphenidate and adolescents with ADHD. This French qualitative study followed the five stages IPSE—Inductive Process to analyze the Structure of lived Experience-approach. Fifteen adolescents with ADHD and 11 CAPs were interviewed. Data collection by purposive sampling continued until data saturation was reached. Data analysis, based on a descriptive and structuring procedure to determine the structure of lived experience characterized by the central axes of experience, produced two axes: (1) The process of methylphenidate prescription, highlighting how this prescription was motivated from the exterior, experienced as passive by the adolescents and required commitment from the CAPs; and (2) the perceived effects of methylphenidate treatment, in three domains: at school, in relationships and in the sense of self. Findings raised both the issues of the epistemic position and social representation of the adolescents about ADHD and methylphenidate within this specific French context, and the self-awareness and perception of the adolescents with ADHD. We conclude that these two issues need to be regularly addressed by the CAPs prescribing methylphenidate to avoid epistemic injustice and prevent the harmful effects of stigmatization. Nature Publishing Group UK 2023-03-10 /pmc/articles/PMC10006242/ /pubmed/36899043 http://dx.doi.org/10.1038/s41598-023-30921-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sibeoni, Jordan Manolios, Emilie Hausser, Clement Delage, Raphael Baylé, Franck Speranza, Mario Verneuil, Laurence Revah-Levy, Anne Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use |
title | Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use |
title_full | Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use |
title_fullStr | Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use |
title_full_unstemmed | Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use |
title_short | Perspectives of French adolescents with ADHD and child and adolescent psychiatrists regarding methylphenidate use |
title_sort | perspectives of french adolescents with adhd and child and adolescent psychiatrists regarding methylphenidate use |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006242/ https://www.ncbi.nlm.nih.gov/pubmed/36899043 http://dx.doi.org/10.1038/s41598-023-30921-4 |
work_keys_str_mv | AT sibeonijordan perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT manoliosemilie perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT hausserclement perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT delageraphael perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT baylefranck perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT speranzamario perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT verneuillaurence perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse AT revahlevyanne perspectivesoffrenchadolescentswithadhdandchildandadolescentpsychiatristsregardingmethylphenidateuse |